Philip Kim

Company: University of Toronto

Job title: Professor & Principal Investigator

Seminars:

Merging Antibody Developability with De Novo Design 2:15 pm

Exploring the interplay between structure and sequence-based biologics design Implementing machine learning tools for structure-based de novo design Highlighting the data challenges that limit thisRead more

day: Day Two